Cookies on this site

DOI

10.1111/ejh.13479

Type

Journal article

Publication Date

01/11/2020

Volume

105

Pages

662 - 666

Total pages

4

Keywords

COVID-19, SARS-CoV-2, infection, myeloma, outcome, therapy, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, COVID-19, Combined Modality Therapy, Disease Management, Forecasting, Hematopoietic Stem Cell Transplantation, Humans, Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Palliative Care, Pandemics, Recurrence, SARS-CoV-2, Salvage Therapy, Transplantation, Autologous, Treatment Outcome, United Kingdom